A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 in Healthy Adult Subjects
Latest Information Update: 21 Jul 2014
At a glance
- Drugs Biapenem (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- Sponsors Rempex Pharmaceuticals
- 30 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2012 New trial record